- Home
- CROX vs TMDX Comparison
CROX vs TMDX Comparison
Compare CROX & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CROX
- TMDX
- Stock Information
- Founded
- CROX 1999
- TMDX 1998
- Country
- CROX United States
- TMDX United States
- Employees
- CROX 7910
- TMDX N/A
- Industry
- CROX Shoe Manufacturing
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CROX Consumer Discretionary
- TMDX Health Care
- Exchange
- CROX Nasdaq
- TMDX Nasdaq
- Market Cap
- CROX 3.9B
- TMDX 4.0B
- IPO Year
- CROX 2006
- TMDX 2019
- Fundamental
- Price
- CROX $74.21
- TMDX $116.00
- Analyst Decision
- CROX Buy
- TMDX Buy
- Analyst Count
- CROX 12
- TMDX 11
- Target Price
- CROX $100.92
- TMDX $130.73
- AVG Volume (30 Days)
- CROX 1.9M
- TMDX 1.0M
- Earning Date
- CROX 10-30-2025
- TMDX 10-29-2025
- Dividend Yield
- CROX N/A
- TMDX N/A
- EPS Growth
- CROX N/A
- TMDX 170.70
- EPS
- CROX 3.26
- TMDX 2.54
- Revenue
- CROX $4,072,780,000.00
- TMDX $566,354,000.00
- Revenue This Year
- CROX N/A
- TMDX $38.84
- Revenue Next Year
- CROX N/A
- TMDX $20.46
- P/E Ratio
- CROX $22.74
- TMDX $45.56
- Revenue Growth
- CROX 0.01
- TMDX 41.20
- 52 Week Low
- CROX $73.52
- TMDX $55.00
- 52 Week High
- CROX $122.84
- TMDX $145.50
- Technical
- Relative Strength Index (RSI)
- CROX 35.23
- TMDX 41.61
- Support Level
- CROX $73.52
- TMDX $115.21
- Resistance Level
- CROX $80.11
- TMDX $125.57
- Average True Range (ATR)
- CROX 3.34
- TMDX 7.65
- MACD
- CROX -0.87
- TMDX -1.67
- Stochastic Oscillator
- CROX 5.13
- TMDX 14.79
About CROX Crocs Inc.
Crocs Inc is engaged in the design, development, marketing, distribution, and sale of casual lifestyle footwear accessories for men, women, and children. The reportable geographic segments of the company are the United States and other Countries.
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.